Lidocaine Hydrochloride Jelly
NDC Package 76329-3012-5
Package Information
Lidocaine Hydrochloride jellies is lidocaine Hydrochloride Jelly USP, 2% is indicated for prevention and control of pain in procedures involving the male and female urethra for topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation (oral and nasal). This formulation utilizes a jelly delivery system. Marketed by International Medication Systems, Limited, this product is identified by NDC 76329-3012 and is authorized under FDA application ANDA086283.
Identification & Billing
- RxCUI: 1011852 - lidocaine HCl 2 % Topical Gel
- RxCUI: 1011852 - lidocaine hydrochloride 0.02 MG/MG Topical Gel
- RxCUI: 1011852 - lidocaine hydrochloride 2 % Topical Jelly
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 76329 - International Medication Systems, Limited
- 76329-3012 - Lidocaine Hydrochloride
- 76329-3012-5 - 25 VIAL, SINGLE-USE in 1 BOX / 5 mL in 1 VIAL, SINGLE-USE
- 76329-3012 - Lidocaine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76329-3012-5 identifies a specific commercial package of 25 vial, single-use in 1 box / 5 ml in 1 vial, single-use of Lidocaine Hydrochloride, a human prescription drug labeled by International Medication Systems, Limited. This jelly is formulated for topical use and contains lidocaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by International Medication Systems, Limited on August 07, 1979. The current certification is valid through December 31, 2026.
How is this International Medication Systems, Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76329301205. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.